08:31 AM EDT, 09/16/2025 (MT Newswires) -- Jyong Biotech ( MENS ) said Tuesday it has completed patient enrollment in its phase II clinical trial of MCS-8, an investigational drug candidate for prostate cancer prevention. Over 700 high-risk subjects have been enrolled in the clinical trial, the company said. The randomized, placebo-controlled trial is being conducted across 20 hospitals in...

LITTLETON, Colo., Sept. 16, 2025 /PRNewswire/ -- Solutions II, a nationally recognized leader in cybersecurity, managed services, hybrid data center transformation, and organizational AI readiness, today announced the acquisition of Vertical VAR, an Atlanta-based value-added reseller known for its relentless client advocacy and deep industry expertise. This acquisition accelerates Solutions II's strategic expansion in the Southeast region—one of the fastest-growing...

Sept 16 (Reuters) - Highland Copper ( HDRSF ) said on Tuesday it received a non-binding letter from the U.S. Export-Import Bank (EXIM) for potential $250 million financing to develop its Copperwood project in Michigan. The indication of interest, issued under EXIM's Make More in America initiative, could cover a substantial portion of Copperwood's estimated $400 million capital cost, the...

IQSTEL ( IQST ) on Tuesday announced that its Fintech Division will play a key role in achieving the company’s previously stated goal of reaching a $15 million EBITDA run rate in 2026. The company completed the acquisition of Globetopper on July 1, 2025, and has since been accelerating its growth as part of its strategic roadmap. Globetopper will likely...